Aquestive Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Warren, NJ
AQST chart
What traders are saying about $AQST
Latest postsAquestive Therapeutics, Inc. news
- Aquestive Therapeutics Stock Price Forecast. Should You Buy AQST?
StockInvest.us ·
- Aquestive Therapeutics Inc (AQST) (Q3 2026) Earnings Call Highli
GuruFocus ·
- Aquestive Therapeutics Inc (AQST) (Q3 2026) Earnings Call Highlights: Revenue Dip Masks Anifilm ...
Yahoo Finance ·
- Leerink Partners Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Raises Target Price to $11
Moomoo ·
- Aquestive Therapeutics Furnishes Investor Presentation for Stakeholders
TipRanks ·
- With $90.3M cash at September 30, 2026, Aquestive (AQST) outlines funding tied to Anaphylm approval.
Stock Titan ·
- Aquestive Therapeutics to Present Data at the 2026 ACAAI Annual Meeting
Yahoo Finance ·
- Aquestive Therapeutics Grants Eton U.S. Libervant Commercialization Rights
The Globe and Mail ·
- Aquestive Therapeutics, Inc. Q3 2026 Earnings Call Summary
app.moby.co ·
- Aquestive (AQST) Q3 2026 Earnings Call Transcript
fool.com ·
- What Aquestive Therapeutics (AQST) Said on Its Q3 Earnings Call
marketbeat.com ·
- Aquestive Therapeutics Q3 2026 Earnings Call Transcript
Benzinga ·
Aquestive Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $44.5M | $57.6M | $50.6M | $47.7M |
| Net income | -$83.8M | -$44.1M | -$7.9M | -$54.4M |
| Diluted EPS | $-0.78 | $-0.51 | $-0.13 | $-1.12 |
| Total assets (year end) | $160.4M | $101.4M | $57.4M | $57.1M |
| Cash and equivalents (year end) | $121.2M | $71.5M | $23.9M | $27.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Aquestive Therapeutics, Inc.
- Ticker
- AQST (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Warren, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1398733
- Former names
- MonoSol Rx, Inc.
Frequently asked questions
What exchange is Aquestive Therapeutics, Inc. listed on?
Aquestive Therapeutics, Inc. trades on the Nasdaq under the ticker symbol AQST.
What industry is Aquestive Therapeutics, Inc. in?
Aquestive Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Aquestive Therapeutics, Inc. headquartered?
Aquestive Therapeutics, Inc.'s business address on file with the SEC is in Warren, NJ.
When does Aquestive Therapeutics, Inc.'s fiscal year end?
Aquestive Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Aquestive Therapeutics, Inc. report?
Aquestive Therapeutics, Inc. reported $44.5M in revenue for calendar year 2025, according to its SEC filings.